Frax Finance has introduced six new foreign-currency stablecoin markets on the Base platform, pairing each local currency token with its dollar-pegged Frax USD (frxUSD). These markets, accessible via AeroXYZ, create new onchain trading routes by using frxUSD as a common reference asset. The tokens involved are AUDF, BRZ, CADD, IDRX, tGBP, and ZARP, each having its own trading pair with frxUSD. This development facilitates digital token exchanges rather than traditional bank transactions, leveraging Base's Ethereum-based transaction processing and frxUSD's stable value against the U.S. dollar.
Frax Finance's new stablecoin pairs on Base offer context for cryptocurrency market activity. For readers following crypto markets, here is Pluang's snapshot as of Oct 20, 2026 07:21 WIB: 32 of 50 major cryptocurrencies rose, 17 fell. Notable movers include BAL at Rp16.297 (+11.14%), BAT at Rp3.477 (+10.29%), and EOS at Rp12.649 (+8.13%).
Anteris Technologies received regulatory approval from Germany's BfArM to start enrolling patients in its global PARADIGM trial for the DurAVR Transcatheter Heart Valve. This approval allows the company to recruit patients at leading German centers, ...
XBiotech announced positive final efficacy results from its phase II TASKIN trial for vilamakitug (XB2001) in refractory metastatic colorectal cancer. The study, funded by the French National Cancer Institute, showed a 61.3% overall survival rate at ...
XBiotech announced positive final results from the Phase II TASKIN study, showing that adding Vilamakitug (XB2001) to standard chemotherapy improved 12-month overall survival to 61.3% in patients with refractory metastatic colorectal cancer, surpassi...
Nvidia announced a nearly $10 billion investment plan to support Europe's AI ecosystem, focusing on four German startups: Agile Robots, Avelios Medical, Mirelo, and Reflex Aerospace. This move aligns with Germany's goal to lead in industrial AI, with...
Recce Pharmaceuticals has reached a key milestone in its Phase 3 trial for treating diabetic foot infections with its RECCE® 327 Gel (R327G). An independent Data Monitoring Committee will review unblinded data from 75 patients, following encouraging ...
